BIO 2.78% 52.5¢ biome australia limited

Ann: Clinical trial on asthma sufferers validates Biome probiotic, page-4

  1. 161 Posts.
    lightbulb Created with Sketch. 33
    Fantastic achievement by BIO and another clinically proven product to their range! It's hard to find many companies this size with such a broad range of products. In my view it plays a big role in de-risking sales growth and they appear to be on track to beat the analysis sales forecasts so this will only further the potential upside.

    Well done to the Bio Team!

 
watchlist Created with Sketch. Add BIO (ASX) to my watchlist
(20min delay)
Last
52.5¢
Change
-0.015(2.78%)
Mkt cap ! $115.0M
Open High Low Value Volume
54.5¢ 57.0¢ 50.0¢ $567.9K 1.070M

Buyers (Bids)

No. Vol. Price($)
2 6923 52.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.5¢ 3600 1
View Market Depth
Last trade - 14.13pm 27/06/2024 (20 minute delay) ?
BIO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.